Guardian Pharmacy Services, Inc. (GRDN) - Net Assets
Based on the latest financial reports, Guardian Pharmacy Services, Inc. (GRDN) has net assets worth $232.42 Million USD as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($426.94 Million) and total liabilities ($194.52 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check GRDN goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $232.42 Million |
| % of Total Assets | 54.44% |
| Annual Growth Rate | 18.1% |
| 5-Year Change | 308.73% |
| 10-Year Change | N/A |
| Growth Volatility | 56.51 |
Guardian Pharmacy Services, Inc. - Net Assets Trend (2018–2025)
This chart illustrates how Guardian Pharmacy Services, Inc.'s net assets have evolved over time, based on quarterly financial data. See how many days can Guardian Pharmacy Services, Inc. fund operations to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for Guardian Pharmacy Services, Inc. (2018–2025)
The table below shows the annual net assets of Guardian Pharmacy Services, Inc. from 2018 to 2025. For live valuation and market cap data, see market value of Guardian Pharmacy Services, Inc..
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $217.92 Million | +45.31% |
| 2024-12-31 | $149.98 Million | +150.55% |
| 2023-12-31 | $59.86 Million | -21.16% |
| 2022-12-31 | $75.93 Million | +42.41% |
| 2021-12-31 | $53.32 Million | -20.50% |
| 2020-12-31 | $67.07 Million | +17.58% |
| 2019-12-31 | $57.04 Million | -16.12% |
| 2018-12-31 | $68.01 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Guardian Pharmacy Services, Inc.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 6634300000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $66.34 Million | 32.24% |
| Common Stock | $63.00K | 0.03% |
| Other Components | $139.35 Million | 67.73% |
| Total Equity | $205.76 Million | 100.00% |
Guardian Pharmacy Services, Inc. Competitors by Market Cap
The table below lists competitors of Guardian Pharmacy Services, Inc. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Slide Insurance Holdings, Inc. Common Stock
NASDAQ:SLDE
|
$2.11 Billion |
|
Energa S.A.
WAR:ENG
|
$2.11 Billion |
|
Zhejiang Semir Garment Co Ltd
SHE:002563
|
$2.11 Billion |
|
ARMOUR Residential REIT Inc
NYSE:ARR
|
$2.11 Billion |
|
Nayax Ltd
NASDAQ:NYAX
|
$2.11 Billion |
|
Oesterr. Post AG
VI:POST
|
$2.11 Billion |
|
Hamilton Insurance Group, Ltd.
NYSE:HG
|
$2.11 Billion |
|
SHARP CORP. ADR/1 O.N.
F:SRPB
|
$2.11 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Guardian Pharmacy Services, Inc.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 142,671,000 to 205,759,000, a change of 63,088,000 (44.2%).
- Net income of 49,219,000 contributed positively to equity growth.
- Share repurchases of 29,039,000 reduced equity.
- New share issuances of 29,039,000 increased equity.
- Other factors increased equity by 13,869,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $49.22 Million | +23.92% |
| Share Repurchases | $29.04 Million | -14.11% |
| Share Issuances | $29.04 Million | +14.11% |
| Other Changes | $13.87 Million | +6.74% |
| Total Change | $- | 44.22% |
Book Value vs Market Value Analysis
This analysis compares Guardian Pharmacy Services, Inc.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 13.05x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 75.84x to 13.05x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2018-12-31 | $0.56 | $42.42 | x |
| 2019-12-31 | $0.94 | $42.42 | x |
| 2020-12-31 | $0.63 | $42.42 | x |
| 2021-12-31 | $0.39 | $42.42 | x |
| 2022-12-31 | $0.70 | $42.42 | x |
| 2023-12-31 | $0.46 | $42.42 | x |
| 2024-12-31 | $2.30 | $42.42 | x |
| 2025-12-31 | $3.25 | $42.42 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Guardian Pharmacy Services, Inc. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 23.92%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 3.40%
- • Asset Turnover: 3.51x
- • Equity Multiplier: 2.01x
- Recent ROE (23.92%) is below the historical average (41.45%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2018 | 43.13% | 2.44% | 3.30x | 5.34x | $11.27 Million |
| 2019 | 38.12% | 3.11% | 3.55x | 3.45x | $16.04 Million |
| 2020 | 51.83% | 2.71% | 3.38x | 5.66x | $16.10 Million |
| 2021 | 68.18% | 2.06% | 3.36x | 9.86x | $13.92 Million |
| 2022 | 82.90% | 3.90% | 3.55x | 5.99x | $31.15 Million |
| 2023 | 84.73% | 2.28% | 3.86x | 9.61x | $21.08 Million |
| 2024 | -61.18% | -7.11% | 3.83x | 2.25x | $-101.55 Million |
| 2025 | 23.92% | 3.40% | 3.51x | 2.01x | $28.64 Million |
Industry Comparison
This section compares Guardian Pharmacy Services, Inc.'s net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $441,613,417
- Average return on equity (ROE) among peers: 9102.22%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Guardian Pharmacy Services, Inc. (GRDN) | $232.42 Million | 43.13% | 0.84x | $2.11 Billion |
| Acadia Healthcare Company Inc (ACHC) | $432.55 Million | 4.72% | 1.27x | $1.52 Billion |
| Addus HomeCare Corporation (ADUS) | $34.58 Million | 11.64% | 2.93x | $1.69 Billion |
| agilon health Inc (AGL) | $661.02 Million | -39.73% | 1.63x | $264.44 Million |
| Airsculpt Technologies Inc (AIRS) | $79.29 Million | -10.41% | 1.65x | $354.84 Million |
| Amedisys Inc (AMED) | $879.72 Million | 12.80% | 0.48x | $3.32 Billion |
| AMN Healthcare Services Inc (AMN) | $284.13 Million | 12.09% | 1.26x | $624.22 Million |
| American Shared Hospital Service (AMS) | $11.83 Million | 169.54% | 1.28x | $8.87 Million |
| American Oncology Network Inc. (AONC) | $24.17K | 90834.23% | 1.03x | $292.48 Million |
| Ardent Health Partners, Inc. (ARDT) | $1.52 Billion | 13.82% | 2.26x | $1.33 Billion |
| Astrana Health Inc (ASTH) | $510.64 Million | 13.50% | 0.70x | $1.90 Billion |
About Guardian Pharmacy Services, Inc.
Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services to help residents of long-term health care facilities (LTCFs) in the United States. The company's individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities, behavioral health… Read more